SCHEMBL2532857

SCHEMBL2532857

CC(=O)N1CCCN(c2nc(N[C@H]3CCN(C(=O)Cc4ccccc4-c4ccccc4)C3)nc3ccccc23)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.40
SMO Q99835 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PDE10A Q9Y233 2/20 0.38
TSHR P16473 2/20 0.37
USP2 O75604 1/20 0.37
NCF1 P14598 2/20 0.36
CNR2 P34972 1/20 0.36
PIK3R1 P27986 3/20 0.36
PIK3CA P42336 3/20 0.36
MTOR P42345 3/20 0.36
MGLL Q99685 1/20 0.36
SMAD3 P84022 1/20 0.36
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2532859 1.00 GBA1 (0.40) GBA1SMOMEN1KMT2APDE10A
SCHEMBL2535150 0.90 GBA1 (0.48) GBA1PDE10A
SCHEMBL2535146 0.90 GBA1 (0.48) GBA1PDE10A
SCHEMBL2539907 0.88 PRKD1 (0.40) GBA1MEN1KMT2ATSHRPIK3R1
SCHEMBL2539903 0.88 PRKD1 (0.40) GBA1MEN1KMT2ATSHRPIK3R1
SCHEMBL2536983 0.87 TSHR (0.43) MEN1KMT2ATSHRPIK3R1PIK3CA
SCHEMBL2536979 0.87 TSHR (0.43) MEN1KMT2ATSHRPIK3R1PIK3CA
Hydrochloric Acid SCHEMBL2539271 0.87 PRKD1 (0.40) GBA1MEN1KMT2ATSHRPIK3R1
Hydrochloric Acid SCHEMBL2539270 0.87 PRKD1 (0.40) GBA1MEN1KMT2ATSHRPIK3R1
SCHEMBL2541309 0.87 DPP4 (0.39) GBA1MEN1KMT2ATSHRPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044068-B2 Aminopyrrolidine compound TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-10-25 US disclosed
US-8044068-B2 Aminopyrrolidine compound TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-10-25 US disclosed
US-20090291940-A1 AMINOPYRROLIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-11-26 US disclosed
US-20090291940-A1 AMINOPYRROLIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-11-26 US disclosed
EP-2003131-A1 AMINOPYRROLIDINE COMPOUND Taisho Pharmaceutical Co. Ltd. (JP) 2008-12-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291940-A1 AMINOPYRROLIDINE COMPOUND MC4R, MC5R, MC2R GBA1 4702/4885SMO 2168/4885MEN1 1210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.